Skip to main content
. 2017 Aug 18;66(11):1886–1899. doi: 10.1136/gutjnl-2017-314109

Table 1.

A summary of the upper gastrointestinal endoscopy quality standards and associated strength of recommendation

Summary of quality standards Grade of evidence Strength of recommendation Agreement
Patients should be assessed for fitness to undergo a diagnostic OGD Weak Strong 100%
Patients should receive appropriate information about the procedure before undergoing an OGD Weak Strong 100%
An appropriate time slot should be allocated dependent on procedure indications and patient characteristics Weak Strong 100%
Informed consent should be obtained before performing an OGD Weak Strong 100%
A safety checklist should be completed before starting an OGD Moderate Strong 100%
A checklist should be undertaken after completing an OGD, before the patient leaves the room Weak Strong 90%
Only an endoscopist with appropriate training and the relevant competencies should independently perform OGD Weak Strong 100%
We suggest that endoscopists should aim to perform a minimum of 100 OGDs a year, to maintain a high-quality examination standard Weak Weak 100%
UGI endoscopy should be performed with high-definition video endoscopy systems, with the ability to capture images and take biopsies Weak Strong 90%
Intravenous sedation and local anaesthetic throat spray can be used in conjunction if required. Caution should be exercised in those at risk of aspiration Moderate Strong 100%
A complete OGD should assess all relevant anatomical landmarks and high-risk stations Weak Strong 100%
Photo-documentation should be made of relevant anatomical landmarks and any detected lesions Weak Strong 100%
The quality of mucosal visualisation should be reported. Weak Strong 100%
Adequate mucosal visualisation should be achieved by a combination of adequate air insufflation, aspiration and the use of mucosal cleansing techniques Moderate Strong 100%
It is suggested that the inspection time during a diagnostic OGD should be recorded for surveillance procedures, such as Barrett’s oesophagus and gastric atrophy/intestinal metaplasia surveillance Weak Weak 90%
Where a lesion is identified, this should be described using the Paris classification and targeted biopsies taken Weak Strong 100%
Endoscopy units should adhere to safe sedation practice Weak Strong 100%
The length of a Barrett’s segment should be classified according to the Prague classification Weak Strong 100%
Where a lesion is identified within a Barrett’s segment, this should be described using the Paris classification and targeted biopsies taken Weak Strong 100%
When no lesions are detected within a Barrett’s segment, biopsies should be taken in accordance with the Seattle protocol Moderate Strong 90%
If squamous neoplasia is suspected, full assessment with enhanced imaging and/or Lugol’s chromo-endoscopy is required Moderate Strong 100%
Oesophageal ulcers and oesophagitis that is grade D or atypical in appearance, should be biopsied, with further evaluation in 6 weeks after PPI therapy Weak Strong 100%
The presence of an inlet patch should be photo-documented Weak Weak 90%
The presence of a hiatus hernia should be documented and measured Weak Weak 100%
Biopsies from two different regions in the oesophagus should be taken to rule out eosinophilic oesophagitis in those presenting with dysphagia/food bolus obstruction, where an alternate cause is not found Moderate Strong 100%
Varices should be described according to a standardised classification Weak Strong 100%
Strictures should be biopsied to exclude malignancy before dilatation Weak Weak 90%
Gastric ulcers should be biopsied and re-evaluated after appropriate treatment, including H. pylori eradication where indicated, within 6–8 weeks Weak strong 90%
Where there are endoscopic features of gastric atrophy or IM separate biopsies from the gastric antrum and body should be taken Weak Weak 100%
Where iron deficiency anaemia is being investigated, separate biopsies from the gastric antrum and body should be taken, as well as duodenal specimens if coeliac serology is positive or has not been previously measured Weak Weak 80%
Where gastric or duodenal ulcers are identified, H. pylori should be tested and eradicated if positive Moderate Strong 100%
The presence of gastric polyps should be recorded, with the number, size, location and morphology described, and representative biopsies taken Moderate Strong 100%
Where coeliac disease is suspected, a minimum of four biopsies should be taken, including representative specimens from the second part of the duodenum and at least one from the duodenal bulb Strong Strong 100%
A malignant looking lesion should be described, photo documented and a minimum of six biopsies taken Weak Strong 100%
After OGD readmission, mortality and complications should be audited Weak Strong 100%
A report summarising the endoscopy findings and recommendations should be produced and the key information provided to the patient before discharge Weak Strong 100%
A method for ensuring histological results are processed must be in place Weak Strong 100%
Endoscopy units should audit rates of failing to diagnose cancer at endoscopy up to 3 years before an oesophago-gastric cancer is diagnosed Weak Strong 100%

IM, intestinal metaplasia; OGD, oesophago-gastro-duodenoscopy; PPI, proton pump inhibitor.